Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma.
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2014
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Glioma
- Focus Adverse reactions
- 14 Apr 2009 Additional lead trial centre Stanford University reported by ClinicalTrials.gov.
- 14 Apr 2009 Actual end date (Apr 2009) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.